Abstract
Nanomaterials with exciting functional properties are being increasingly used for therapeutic applications. Research studies over the past decade have shown that properties that make nanomaterials useful for their therapeutic application may also give rise to potential hazardous outcomes. Experimental evidences suggest that variations in nanomaterial size, shape, aspect ratio, surface chemistry, dispersal state and bio-persistence in addition to material ‘specific’ properties could all contribute individually or combinatorially to biological injury via toxicological pathways. While nanomaterial-induced injury pathways could be associated with human disease conditions, it should be noted that currently, there is no human disease that can be directly related to the exposure to engineered nanomaterials. Therefore, in this book chapter, the term ‘toxicity’ is referring to nanomaterial-induced injury mechanisms from experimental studies and details the major properties of nanomaterials in relation to their potential adverse outcomes. In addition, topics on strategies to elucidate property–activity relationships, merits and demerits of cellular models and animal models of toxicology and the use of high-throughput screening for rapid identification of ‘danger signal’ has been emphasized to provide the reader with a comprehensive understanding on the discipline of ‘nanotoxicology’.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Meyer DE, Curran MA, Gonzalez MA. An examination of existing data for the industrial manufacture and use of nanocomponents and their role in the life cycle impact of nanoproducts. Environ Sci Technol. 2009;43(5):1256–63.
The National Nanotechnology Initiative Strategic Plan, 2004, Nanoscale Science, Engineering, and Technology Subcommittee. National Science and Technology Council, Executive Office of the President; 2004.
Nel A, et al. Toxic potential of materials at the nanolevel. Science. 2006;311(5761):622–7.
Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113.
Xia T, Li N, Nel AE. Potential health impact of nanoparticles. Annu Rev Public Health. 2009;30(1):137–50.
ICRP. Human respiratory tract model for radiological protection. A report of a Task Group of the International Commission on Radiological Protection. Ann ICRP. 1994;24:1–482.
Gao H, Shi W, Freund LB. Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci U S A. 2005;102(27):9469–74.
Li X. Size and shape effects on receptor-mediated endocytosis of nanoparticles. J Appl Phys. 2012;111(2) doi:10.1063/1.3676448.
Garnett MC, Kallinteri P. Nanomedicines and nanotoxicology: some physiological principles. Occup Med. 2006;56(5):307–11.
Pan Y, et al. Size-dependent cytotoxicity of gold nanoparticles. Small. 2007;3(11):1941–9.
Allouni ZE, et al. Agglomeration and sedimentation of TiO2 nanoparticles in cell culture medium. Colloids Surf B Biointerfaces. 2009;68(1):83–7.
Derjaguin BV, Landau LD. Theory of the stability of strongly charged lyophobic sols and of the adhesion of strongly charged particles in solutions of electrolytes. Acta Physicochim URSS. 1941;14:733–62.
Rezwan K, et al. Change of xi potential of biocompatible colloidal oxide particles upon adsorption of bovine serum albumin and lysozyme. J Phys Chem B. 2005;109(30):14469–74.
Jiang JK, Oberdorster G, Biswas P. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res. 2009;11(1):77–89.
Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005;26(18):3995–4021.
Hajdú A, et al. Surface charging, polyanionic coating and colloid stability of magnetite nanoparticles. Colloids Surf A Physicochem Eng Aspects. 2009;347(1–3):104–8.
Schulze C, et al. Not ready to use – overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicology. 2008;2(2):51–U17.
Foucaud L, et al. Measurement of reactive species production by nanoparticles prepared in biologically relevant media. Toxicol Lett. 2007;174(1–3):1–9.
Bihari P, et al. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part Fibre Toxicol. 2008;5(1):14.
Porter D, et al. A biocompatible medium for nanoparticle dispersion. Nanotoxicology. 2008;2(3):144–54.
Ji Z, et al. Dispersion and stability optimization of TiO2 nanoparticles in cell culture media. Environ Sci Technol. 2010;44:7309–14.
George S, et al. Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. ACS Nano. 2010;4(1):15–29.
George S, et al. Surface defects on plate-shaped silver nanoparticles contribute to its hazard potential in a fish gill cell line and zebrafish embryos. ACS Nano. 2012;6(5):3745–59.
Wang X, Xia T, Ntim SA, Ji ZX, George S, Meng H, Zhang HY, Castranova V, Mitra S, Nel AE. Quantitative techniques for assessing and controlling the dispersion and biological effects of multiwalled carbon nanotubes in mammalian tissue culture cells. ACS Nano. 2010;4:7241–52.
Wang X, Xian T, Ntim SA, Ji Z, Lin S, Meng H, Chung C, George S, Zhang H, Wang M, Li N, Yang Y, Castranova V, Mitra S, Bonner J, Nel AE. Dispersal state of multiwalled carbon nanotubes elicits profibrogenic cellular responses that correlate with fibrogenesis biomarkers and fibrosis in the murine lung. ACS Nano. 2011;5:9772–87.
Decuzzi P, et al. Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release. 2010;141(3):320–7.
Meng H, et al. Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. ACS Nano. 2011;5(6):4434–47.
Stanton MF, Layard M, Tegeris A, Miller E, May M, Morgan E, Smith A. Relation of particle dimension to carcinogenicity in Amphibole Asbestoses and other fibrous minerals. J Natl Cancer Inst. 1981;67:965–75.
Donaldson K, et al. Pulmonary toxicity of carbon nanotubes and asbestos — similarities and differences. Adv Drug Deliv Rev. 2013;65(15):2078–86.
Wagner JC, Berry G. Mesothdiomas in rats following inoculation with asbestos. Br J Cancer. 1969;23:567–81.
Davis JMG. A review of experimental evidence for the carcinogenicity of man-made vitreous fibres. Scand J Work Environ Health. 1986;12:12–7.
Lippmann M. Effects of fiber characteristics on lung deposition, retention, and disease. Environ Health Perspect. 1990;88:311–7.
Tsuda A, et al. Alveolar cell stretching in the presence of fibrous particles induces interleukin-8 responses. Am J Respir Cell Mol Biol. 1999;21(4):455–62.
Brown SC, et al. Influence of shape, adhesion and simulated lung mechanics on amorphous silica nanoparticle toxicity. Adv Powder Technol. 2007;18(1):69–79.
Ji Z, et al. Designed synthesis of CeO2 nanorods and nanowires for studying toxicological effects of high aspect ratio nanomaterials. ACS Nano. 2012;6(6):5366–80.
Perrault SD, et al. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 2009;9(5):1909–15.
Meng H, et al. Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. ACS Nano. 2013;7(2):994–1005.
Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes. J Invest Dermatol. 2007;127(1):143–53.
Lovric J, et al. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med. 2005;83(5):377–85.
Verma A, et al. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater. 2008;7(7):588–95.
Stasko NA, et al. Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells. Biomacromolecules. 2007;8(12):3853–9.
Sayes CM, et al. The differential cytotoxicity of water-soluble fullerenes. Nano Lett. 2004;4(10):1881–7.
Sayes CM, et al. Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett. 2006;161(2):135–42.
Aydin Sevinç B, Hanley L, Antibacterial activity of dental composites containing zinc oxide nanoparticles. J Biomed Mater Res B Appl Biomater. 2010;94B(1):22–31.
George S, et al. Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. ACS Nano. 2011;5(3):1805–17.
Xia T, et al. Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. ACS Nano. 2011;5(2):1223–35.
Saha N, Dubey AK, Basu B. Cellular proliferation, cellular viability, and biocompatibility of HA-ZnO composites. J Biomed Mater Res B Appl Biomater. 2012;100B(1):256–64.
Sousa CJA, et al. Synthesis and characterization of zinc oxide nanocrystals and histologic evaluation of their biocompatibility by means of intraosseous implants. Int Endod J. 2014;47:416–24.
Lührs AK, Geurtsen W. The application of silicon and silicates in dentistry: a review. In: Müller WG, Grachev M, editors. Biosilica in evolution, morphogenesis, and nanobiotechnology. Berlin/Heidelberg: Springer; 2009. p. 359–80.
Castranova V, Vallyathan V. Silicosis and coal workers’ pneumoconiosis. Environ Health Perspect. 2000;108:675–84.
Elias Z, et al. Cytotoxic and transforming effects of silica particles with different surface properties in Syrian hamster embryo (SHE) cells. Toxicol In Vitro. 2000;14(5):409–22.
Donaldson K, Tran CL. Inflammation caused by particles and fibers. Inhal Toxicol. 2002;14(1):5–27.
Rimal B, Greenberg AK, Rom WN. Basic pathogenetic mechanisms in sificosis: current understanding. Curr Opin Pulm Med. 2005;11(2):169–73.
Dutta D, Moudgil BM. Crystalline silica particles mediated lung injury. Kona Powder Part. 2007;25:76–87.
Zhang H, et al. Processing pathway dependence of amorphous silica nanoparticle toxicity: colloidal vs pyrolytic. J Am Chem Soc. 2012;134(38):15790–804.
Melo MAS, et al. Novel dental adhesives containing nanoparticles of silver and amorphous calcium phosphate. Dent Mater. 2013;29(2):199–210.
Ahn S-J, et al. Experimental antimicrobial orthodontic adhesives using nanofillers and silver nanoparticles. Dent Mater. 2009;25(2):206–13.
Navarro E, et al. Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ Sci Technol. 2008;42(23):8959–64.
Zhao C-M, Wang W-X. Comparison of acute and chronic toxicity of silver nanoparticles and silver nitrate to Daphnia magna. Environ Toxicol Chem. 2011;30(4):885–92.
Glover RD, Miller JM, Hutchison JE. Nanoparticle dynamics on surfaces and potential sources of nanoparticles in the environment. ACS Nano. 2011;22:8950–7.
Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium escherichia coli. Appl Environ Microbiol. 2007;73(6):1712–20.
Morones JR, et al. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16(10):2346.
Xinling TM, Tsuji, Syntheses of silver nanowires in liquid phase. Nanowires Science and Technology, Nicoleta Lupu (Ed.), ISBN: 978-953-7619-89-3, InTech, Available from: http://www.intechopen.com/books/nanowires-science-and-technology/syntheses-of-silver-nanowires-in-liquid-phase. 2010. Last accessed on Oct 29 2014.
Cui F-Z, Ge J. New observations of the hierarchical structure of human enamel, from nanoscale to microscale. J Tissue Eng Regen Med. 2007;1(3):185–91.
Imbeni V, et al. The dentin-enamel junction and the fracture of human teeth. Nat Mater. 2005;4(3):229–32.
Catledge SA, et al. Nanostructured ceramics for biomedical implants. J Nanosci Nanotechnol. 2002;2(3–1):293–312.
Reynolds EC, et al. Fluoride and casein phosphopeptide-amorphous calcium phosphate. J Dent Res. 2008;87(4):344–8.
Huang S, et al. Remineralization potential of nano-hydroxyapatite on initial enamel lesions: an in vitro study. Caries Res. 2011;45(5):460–8.
Chen L, et al. The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells. Nanotechnology. 2011;22(10):105708.
Yuan Y, et al. Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells. Biomaterials. 2010;31(4):730–40.
Shi Z, et al. Size effect of hydroxyapatite nanoparticles on proliferation and apoptosis of osteoblast-like cells. Acta Biomater. 2009;5(1):338–45.
Cho MJ, et al. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett. 2009;189(3):177–83.
Fitzpatrick JAJ, et al. Long-term persistence and spectral blue shifting of quantum dots in vivo. Nano Lett. 2009;9(7):2736–41.
Chen Z, Chen H, Meng H, Xing G, Gao X, Sun B, Shi X, Yuan H, Zhang C, Liu R, Zhao F, Zhao Y, Fang X. Bio-distribution and metabolic paths of silica coated CdSeS quantum dots. Toxicol Appl Pharmacol. 2008;230:364–71.
Chen YS, et al. Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res Lett. 2009;4(8):858–64.
Hartung T. Toxicology for the twenty-first century. Nature. 2009;460(7252):208–12.
Choi JY, Ramachandran G, Kandlikar M. The impact of toxicity testing costs on nanomaterial regulation. Environ Sci Technol. 2009;43(9):3030–4.
Gilbert N. Chemical-safety costs uncertain. Nature. 2009;460:1065.
Abbott A. Toxicity testing gets a makeover. Nature. 2009;461:158.
Damoiseaux R, et al. No time to lose-high throughput screening to assess nanomaterial safety. Nanoscale. 2011;3(4):1345–60.
Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant staphylococcus aureus infection. Clin Infect Dis. 2008;46(Supplement 5):350–9.
Olmedo DG, et al. Effect of titanium dioxide on the oxidative metabolism of alveolar macrophages: an experimental study in rats. J Biomed Mater Res A. 2005;73A(2):142–9.
Wang J, et al. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett. 2007;168(2):176–85.
Meng H, et al. A predictive toxicological paradigm for the safety assessment of nanomaterials. ACS Nano. 2009;3(7):1620–7.
Li N, et al. Particulate air pollutants and asthma. A paradigm for the role of oxidative stress in PM-induced adverse health effects. Clin Immunol. 2003;109(3):250–65.
Nel AE, et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater. 2009;8:543–57.
Xia T, et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006;6(8):1794–807.
Xia T, et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano. 2008;2(10):2121–34.
Xia T, et al. Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. ACS Nano. 2008;2(1):85–96.
Jung EJ, et al. Pro-oxidative DEP chemicals induce heat shock proteins and an unfolding protein response in a bronchial epithelial cell line as determined by DIGE analysis. Proteomics. 2007;7(21):3906–18.
Xiao GG, et al. Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line. J Biol Chem. 2003;278(50):50781–90.
Araujo JA, et al. Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ Res. 2008;102(5):589–96.
Li N, Xia T, Nel AE. The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles. Free Radic Biol Med. 2008;44(9):1689–99.
Li N, et al. The adjuvant effect of ambient particulate matter is closely reflected by the particulate oxidant potential. Environ Health Perspect. 2009;117(7):1116–23.
Araujo J, Nel A. Particulate matter and atherosclerosis: role of particle size, composition and oxidative stress. Part Fibre Toxicol. 2009;6(1):24.
Martin CJ, et al. Zinc exposure in Chinese foundry workers. Am J Ind Med. 1999;35(6):574–80.
Rohrs LC. Metal-fume fever from inhaling zinc oxide. Arch Intern Med. 1957;100(1):44–9.
Gordon T, Fine JM. Metal fume fever. Occup Med State Art Rev. 1993;8(3):505–17.
Wang ZX, et al. Global gene expression profiling in whole-blood samples from individuals exposed to metal fumes. Environ Health Perspect. 2005;113(2):233–41.
Galluzzi L, et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ. 2009;16(8):1093–107.
Casey A, et al. Spectroscopic analysis confirms the interactions between single walled carbon nanotubes and various dyes commonly used to assess cytotoxicity. Carbon. 2007;45(7):1425–32.
Worle-Knirsch JM, Pulskamp K, Krug HF. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 2006;6(6):1261–8.
Monteiro-Riviere NA, Inman AO, Zhang LW. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol. 2009;234(2):222–35.
Kroll A, et al. Current in vitro methods in nanoparticle risk assessment: limitations and challenges. Eur J Pharm Biopharm. 2009;72(2):370–7.
Zhang H, et al. Differential expression of syndecan-1 mediates cationic nanoparticle toxicity in undifferentiated versus differentiated normal human bronchial epithelial cells. ACS Nano. 2011;5(4):2756–69.
Li R, et al. Surface interactions with compartmentalized cellular phosphates explain rare earth oxide nanoparticle hazard and provide opportunities for safer design. ACS Nano. 2014;8:1771–83.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
George, S. (2015). Nanomaterial Properties: Implications for Safe Medical Applications of Nanotechnology. In: Kishen, A. (eds) Nanotechnology in Endodontics. Springer, Cham. https://doi.org/10.1007/978-3-319-13575-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-13575-5_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-13574-8
Online ISBN: 978-3-319-13575-5
eBook Packages: MedicineMedicine (R0)